Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Barriers to Colonoscopy Completion Span Multiple Realms
11/02/2021
Patients with abnormal results on fecal immunochemical test may need multilevel interventions to ensure completed colonoscopies.
Patients with abnormal results on fecal immunochemical test may need multilevel interventions to ensure completed colonoscopies.
Patients with abnormal results...
11/02/2021
Gastroenterology
News
Fatty Liver Disease Found in One-Third of HBV Cohort
10/06/2021
Steatohepatitis is associated with disease progression among patients with hepatitis B virus.
Steatohepatitis is associated with disease progression among patients with hepatitis B virus.
Steatohepatitis is associated...
10/06/2021
Gastroenterology

Advertisement

News
New Score Gauges HCC Risk in Patients With Chronic Hepatitis B
09/21/2021
Decreased noninvasive fibrosis markers predict reduction in risk of hepatocellular cancer among patients with hepatitis B, investigators find.
Decreased noninvasive fibrosis markers predict reduction in risk of hepatocellular cancer among patients with hepatitis B, investigators find.
Decreased noninvasive fibrosis...
09/21/2021
Gastroenterology
News
Patients With Celiac Disease May Have Higher Cancer Risks
08/26/2021
Age at diagnosis may be the primary factor driving cancer risks among patients with celiac disease.
Age at diagnosis may be the primary factor driving cancer risks among patients with celiac disease.
Age at diagnosis may be the...
08/26/2021
Gastroenterology
News
FDA Grants Approval to First COVID-19 Vaccine
08/22/2021
The Pfizer-BioNTech vaccine was approved under the agency’s Priority Review process for use among individuals 16 or older.
The Pfizer-BioNTech vaccine was approved under the agency’s Priority Review process for use among individuals 16 or older.
The Pfizer-BioNTech vaccine was...
08/22/2021
Gastroenterology

Advertisement

News
Antiviral Prophylaxis Cuts Risk of HBV Reactivation With Immune Checkpoint Inhibitors
08/17/2021
Hepatitis B virus (HBV) reactivation was rare in patients with antiviral prophylaxis receiving immune checkpoint inhibitor treatment for cancer, according to study findings published online ahead of print in Clinical Gastroenterology and...
Hepatitis B virus (HBV) reactivation was rare in patients with antiviral prophylaxis receiving immune checkpoint inhibitor treatment for cancer, according to study findings published online ahead of print in Clinical Gastroenterology and...
Hepatitis B virus (HBV)...
08/17/2021
Gastroenterology
News
Antiviral Treatment for Chronic Hepatitis B Reduces Risks
08/09/2021
Therapy showed significant reduction in cirrhosis, liver cancer, and death.
Therapy showed significant reduction in cirrhosis, liver cancer, and death.
Therapy showed significant...
08/09/2021
Gastroenterology
News
Less Invasive Surgery for Esophageal Cancer Proves Better Option
07/22/2021
McKeown-MIE proved to be the better option for long-term survival among patients with esophageal cancer, according to a recent study.
McKeown-MIE proved to be the better option for long-term survival among patients with esophageal cancer, according to a recent study.
McKeown-MIE proved to be the...
07/22/2021
Gastroenterology

Advertisement

News
AGA Issues Best Practice Advice for Chemoprevention of CRC
07/16/2021
In an expert review, the American Gastroenterological Association provides guidance for use of aspirin and other medications that may help prevent colorectal neoplasia.
In an expert review, the American Gastroenterological Association provides guidance for use of aspirin and other medications that may help prevent colorectal neoplasia.
In an expert review, the...
07/16/2021
Gastroenterology
News
MACE Shows Independent Association With Hepatic Steatosis
07/15/2021
While the association of hepatic steatosis with MACE has been apparent for some time, whether this association occurs when patients have no pre-existing coronary artery disease has not been clear.
While the association of hepatic steatosis with MACE has been apparent for some time, whether this association occurs when patients have no pre-existing coronary artery disease has not been clear.
While the association of hepatic...
07/15/2021
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Colonoscopy After Diverticulitis Usually Unnecessary
11/14/2024
In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.
In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.
In colonoscopies performed...
11/14/2024
Gastroenterology
News
Upper Gl Mucosal Damage Associated With Parkinson's Disease
10/18/2024
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI)...
10/18/2024
Gastroenterology
News
Vonoprozan Compared to PPIs for Peptic Ulcer Rebleeding Prevention
10/18/2024
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective...
10/18/2024
Gastroenterology
News
NAFLD or MASLD? Research Looks at Concordance of Criteria
10/18/2024
New nomenclature shows strong applicability in real-world clinical settings.
New nomenclature shows strong applicability in real-world clinical settings.
New nomenclature shows strong...
10/18/2024
Gastroenterology
News
Liver Histology Impact on Long-Term Clinical Outcomes in MASH
10/18/2024
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower...
10/18/2024
Gastroenterology
News
AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD
10/18/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of...
10/18/2024
Gastroenterology
News
New Age Recommendation Yields Uptake in CRC Screening But Disparities Found
10/18/2024
Income level and location drove variations in rates of increase, authors of a retrospective cohort study found.
Income level and location drove variations in rates of increase, authors of a retrospective cohort study found.
Income level and location drove...
10/18/2024
Gastroenterology
News
Repeat FIT Offers Greater Differentiation of Patients With, Without Significant Pathology
10/09/2024
Conducting repeat fecal immunochemical tests doubled the detection rates of colorectal cancer and significant bowel disease, researchers reported.
Conducting repeat fecal immunochemical tests doubled the detection rates of colorectal cancer and significant bowel disease, researchers reported.
Conducting repeat fecal...
10/09/2024
Gastroenterology
News
AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD
10/08/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of...
10/08/2024
Gastroenterology
News
FDA Approves Cologuard Plus
10/07/2024
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug...
10/07/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use